title: [Subacute encephalopathy of early onset during treatment of relapse of lymphoblastosis in a young infant].
authors.forename: A
authors.initials: A
authors.lastname: Donadio
authors.forename: D
authors.initials: D
authors.lastname: Dossa
authors.forename: F
authors.initials: F
authors.lastname: Montoya
authors.forename: G
authors.initials: G
authors.lastname: Margueritte
authors.forename: D
authors.initials: D
authors.lastname: Rieu
authors.forename: M
authors.initials: M
authors.lastname: Navarro
authors.forename: R
authors.initials: R
authors.lastname: Jean
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D001284:Atrophy; D001921:Brain / Q000187:drug effects / Q000473:pathology; D002531:Cerebellum / Q000473:pathology; D002552:Cerebral Ventricles / Q000473:pathology; D003131:Combined Modality Therapy; D016371:Cranial Irradiation / Q000009:adverse effects; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects; D004827:Epilepsy / Q000209:etiology / Q000473:pathology; D006801:Humans; D007223:Infant; D007278:Injections, Spinal; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D008297:Male; D020258:Neurotoxicity Syndromes / Q000175:diagnosis / Q000209:etiology*; D010286:Paraventricular Hypothalamic Nucleus / Q000473:pathology; D012008:Recurrence; D012074:Remission Induction
chemical_list: D003561:Cytarabine